MHC-1 Genotypes Restricts The Oncogenic Mutational Landscape

摘要

The present disclosure provides methods of determining the risk of a subject having or developing a cancer or autoimmune disorder based on the affinity of the subjects MHC-I alleles for oncogenic mutations or peptides linked with autoimmune disorders, methods for improving cancer diagnosis, and kits comprising agents that detect the oncogenic mutations in a subject.